Case Report
Copyright ©The Author(s) 2021.
World J Clin Cases. Sep 26, 2021; 9(27): 8071-8081
Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.8071
Table 1 Nineteen cases of pancreatic paraganglioma from literature review
Ref.SexAgeSize (cm)LocationImaging featuresManifestationPreoperative diagnosisTherapyFollow-up
Fujino et al[5], 1998M612.5 × 2.0 × 1.8Uncinate processCT: A solid mass. MRI: An isointensity lesion. CA: A hypervascular tumorNFPan-NENPD5 yr PO (TF)
Parithivel et al[6], 2000M856HeadCT: A highly vascular solid-cystic mass, no dilation of either biliary or pancreatic ductsNFNMTLRNM
Ohkawara et al[7], 2005F724HeadCT: A solid-cystic tumor rich in blood supply, no dilation of either biliary or pancreatic ductsNFPan-NENRPHNM
Kim et al[8], 2008F576.5 × 6 × 6HeadUS: A hypervascular tumor. CT: Marked enhancement in the arterial phase, still well-enhancing in the portal venous phase, non-enhancing tubular-shaped portions could be seen inside. EUS: Echogenic mass with several anechoic portionsNFPancreatic islet cell tumor PPPDNM
He et al[9], 2011F404.5 × 4.2Uncinate processCT: Well demarcated solid mass, dramatical enhancement in pancreatic and portal vein phase, several low density foci were observed. Distal pancreatic duct middle dilationNFNMRPHNM
Higa and Kapur[10], 2012F652.0Uncinate processCT: A pancreatic mass with enhancement and mixed attenuationNFNMPDNM
Al-Jiffry et al[11], 2013F199.0HeadCT: Marked enhancement in the arterial phase and washed out in the venous phaseFPancreatic sarcomaPD3 yr PO (TF)
Borgohain et al[12], 2013F5517 × 19TailCT: A multi-cystic tumor. US: Highly vascularNFNMTLR10 mo PO (TF)
Straka et al[13], 2014F538.5HeadCT: An extremely hypervascular tumor with abundant collateral vessels from the superior mesenteric arteryNFNMPPPD49 mo PO (TF)
Zhang et al[14], 2014F506HeadCT: A solid well-vascularized tumor, with multiple liver metastasesFNMOperation halted4 yr PO (TF)
Zhang et al[14], 2014M634HeadCT: Well-vascularized tumorFNMOperation3 mo PO (TF)
Meng et al[15], 2015F543 × 2.5HeadUS: An ill-defined hypoechoic mass, the blood flow signal was plentiful. CT: a poor-defined isodense mass, heterogeneous striking enhancement during the arterial phase, homogeneous marked enhancement during the venous phaseNFNMOperationNM
Meng et al[15], 2015F414 × 4HeadUS: A well-demarcated hypoechoic mass, some blood flow signal was seen. CT: a poor-defined mass with low and heterogeneous density, marked enhancementNFNMOperationNM
Misumi et al[16], 2015F471.5 × 1.2HeadUS: A low-echoic tumor, CT: A well demarcated tumor, strongly enhanced in the arterial phase and still faintly enhanced in the portal vein phase. Feeding artery from the inferior pancreaticoduodenal artery and the draining vein into the portal vein. no dilation of either biliary or pancreatic ductsNFPan-NENPD1 yr PO (TF)
Ginesu et al[17], 2016M551.3Uncinate processCT: Arterial phase hypervascularity and slow wash-outNFPan-NENPPPD2 yr PO (TF)
Tulumuru et al[18], 2016F622.8 × 2.8 × 2.7BodyCT: Well-defined margin and avid homogeneous enhancement. No lymphadenopathy or metastasisNFPan-NENDP1 yr PO (TF)
Lin et al[1], 2016F425.2 × 6.3BodyCT: Marked enhancement in the arterial phase, distal pancreatic duct dilationNFPan-NENCP1 yr PO (TF)
Furcea et al[19], 2017F533.5 × 2.5 × 2.5IsthmusUS: Encapsulated hypoechoic, inhomogeneous tumor. CEUS: intense arterial enhancement, rich arterial vascularizationNFPan-NENCPNM
Nonaka et al[20], 2017F682.2 × 2.2 × 1.7HeadEUS: Low-echoic nodule. No dilation of either biliary or pancreatic ducts. CT: enhanced during the arterial phase, weakly enhanced during the portal phaseNFNMPPPD1 yr PO (TF)